Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
Clinical trial NCT02021318 · COMPLETED
Trial details
- NCT number
- NCT02021318
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-12
- Primary completion
- 2018-03-23
- Enrollment
- 616
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.